Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use
A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study
Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.
Treatment of Ductal Carcinoma In Situ Among Patients Cared for in Large Integrated Health Plans
Although we found no DCIS treatment disparities by race/ethnicity, use of adjuvant radiation therapy was less among older women and among residents of poorer neighborhoods.
